Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Forecast
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Cancer Institute is seeking to support the Canine Cancer Immunotherapy Network (K9CIN) through five U01 awards to advance cancer immunotherapy trials in pet dogs. Because canine cancers develop spontaneously and mirror human disease progression, these trials provide critical preclinical data on immune responses and the efficacy of novel or repurposed drugs. The initiative aims to maintain momentum in developing canine analytics and therapeutics, offering cutting-edge treatments to pet dogs while generating translatable data for human medical applications. The funding structure consists of one multifunctional Network Coordinating Center responsible for network facilitation and limited research, and four separate awards dedicated to conducting clinical trials using immunotherapeutic agents alone or in combination with other modalities. This consolidated opportunity streamlines previous funding paths to support the evaluation of treatment dosing, sequencing, and correlative studies.

General Info

Funding to support canine cancer immunotherapy trials via a collaborative NIH network for translational research.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Get what you need to respond

No documents were posted with this contract.

  • Buyer contactEmail and phone
  • Original solicitationLink to the source posting
Get the buyer contact

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseForecast
Posted

forecast

Prepare for this forecast

Research the agency, track this forecast, and prepare your capture plan before the solicitation opens.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA

Full Description

Show more

The goal of this RFA is to continue to support canine cancer immunotherapy clinical trials as indicators of safe and effective cancer treatments in humans. Pet dog patients develop cancer spontaneously and the courses of disease and treatment responses are similar to those in humans. Canine clinical trial results are translatable to humans. The assessment of responses to immunotherapy in immune-intact animals with existing cancers, such as pet dog patients, is the only way to preclinically take into account all facets of the immune response to cancer and to therapies. Ethically, pet dogs can benefit from the clinical trials by receiving cutting-edge therapies supported by the NIH, while providing important data informative to human disease. The network supported by this U01 RFA will consist of five U01 awards. One U01 will serve as a multifunctional Network Coordinating Center that will not only facilitate coordination across the Canine Cancer Immunotherapy Network (K9CIN) but will also perform limited research to support the network. Four U01 recipients will conduct canine clinical trials using immunotherapeutic agents alone or in combination with other treatment modalities.

Through this reissue Notice of Funding Opportunity, the National Cancer Institute intends to continue to support canine immunotherapeutic development as the field continues to grow, in part because of NIH funding. In the last five years, canine immunotherapeutics such as immune checkpoint inhibitors have become available as have canine analytics, development of which were partially supported by NCI. The goal is to maintain the momentum for further development of canine analytics and therapeutics and the ability to evaluate novel and repurposed drugs, treatment combinations, and treatment dosing and sequencing in pet dogs in a timely fashion. This NOFO consolidates the prior U01 (RFA-CA-21-050) and U24 (RFA-CA-21-051) funding opportunities to streamline the application process for continued support to K9CIN. Applicants have the option of submitting either for the Network Coordinating Center with limited research focus or for conducting canine cancer immunotherapy clinical trials and correlative studies. These important canine cancer-related activities will provide a valuable opportunity for NIH support to benefit humans and dogs, at both ends of the leash.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
APEX Arsenal Solutions Marketplace
Solicitation # HQ0034-27-S-CAPX
The APEX Arsenal Solutions Marketplace (AASM) is a long-term open call initiated by the Department of War (DoW) Office of Industrial Base Growth, managed by the Applied Research Institute and supported by the Washington Headquarters Services Acquisition Directorate. This initiative seeks to identify and curate hardware, software, systems, and workforce development solutions that strengthen the defense industrial base and close critical capability gaps for the Warfighter. The program focuses on the development, scaling, and sustainment of emerging technologies and critical materials, making these solutions available for procurement through rapid acquisition pathways. The submission window runs from December 1, 2026, through November 30, 2027, with submissions collected in monthly cycles. Applicants must submit an unclassified .mp4 video no longer than five minutes and a completed submission form detailing their organization name, Unique Entity Identifier (UEI), and Technology Readiness Level (TRL). Submissions are evaluated by a peer panel of subject matter experts and a Government Selecting Official based on the clarity of the problem description, the strength of the proposed solution, the degree of technological advancement over current capabilities, and the viability of the business model. To maintain integrity, strict organizational conflict of interest protocols are in place, prohibiting assessors from evaluating their own technologies or those in which they hold a financial interest.
Washington Headquarters Services

POSTED

about 7 hours ago

DEADLINE

in about 1 year
View Details
NAICS: 541715
New
Federal
NSF X-Labs Initiative - Computation at the Limit of Physics
Solicitation # NSF-Topic5-FY27-XLabsComputation
The National Science Foundation (NSF) Directorate for Technology, Innovation and Partnerships is soliciting written proposals for the NSF X-Labs Initiative focusing on Computation at the Limit of Physics. This initiative seeks to develop novel platform technologies that significantly reduce the gap between the energy efficiency of conventional CMOS-based computing and inherent physical limits, such as the Landauer Limit. The goal is to achieve 4-5 orders-of-magnitude improvements in effective computational throughput per unit power through the exploration of alternative device technologies, logic frameworks, and memory technologies, including superconducting microelectronics and reversible logic. Awards will be issued as Other Transaction (OT) contracts pursuant to 42 U.S.C §19116, meaning they are not FAR-based procurement contracts or financial assistance instruments. The project is structured in phases, starting with a Phase 0 lasting 9 to 12 months beginning in October 2027, followed by a Phase 1 lasting 24 to 36 months starting in July 2028, and a variable Phase 2 for high-performing teams. Funding for Phase 1 is capped at a maximum of $1,500,000, with payments structured as quarterly milestones based on successful completion and NSF acceptance. Proposals are evaluated on two equally weighted factors: Team Qualifications and Structure, and Mission Clarity and Outcomes. The selection process is a competitive down-select involving a written proposal, followed by an invitation for an oral proposal package and presentation for selected teams. Written proposals must be submitted as a PDF of no more than 8 single-sided pages using 12-point font by March 15, 2027. Lead organizations must be registered in the System for Award Management (SAM) and provide a Unique Entity Identifier (UEI). Additionally, all proposals must include a signed Conflict of Interest statement governed by the framework of FAR Subpart 9.5 and comply with research security requirements of the CHIPS and Science Act of 2022.
Division Of Acq And Cooperative Support

POSTED

about 7 hours ago

DEADLINE

in 4 months
View Details
NAICS: 541715
New
SBIR / STTR
Ground-Based Affordable Mass (G-BAM)
Solicitation # ARM26BX04-DV010
The Ground-Based Affordable Mass (G-BAM) solicitation, issued by the U.S. Army under the U.S. Department of Defense, is a total small business set-aside opportunity utilizing a direct-to-Phase II SBIR structure. The program is designed as a three-phased effort, where Phase I typically lasts six to twelve months and Phase II generally spans 24 months. Proposals are submitted via the DSIP portal and must be organized into seven specific volumes, including technical, cost, and commercialization reports. Technical proposals must adhere to strict formatting guidelines, including a single PDF format, one-inch margins, and a minimum 10-point font, with a risk of rejection if page limits are exceeded. Award selections are based on the overall technical value and cost, with a primary focus on technical capability, innovation, and the qualifications of key personnel. Evaluation factors are prioritized by the soundness of the technical approach, the ability of the team to perform R&D and commercialize results, and the overall commercial potential for government or private sector application. To be eligible, proposing entities must be registered in the System for Award Management (SAM) and the SBA Company Registry. Additionally, contractors must comply with stringent security and legal requirements, including the Cybersecurity Maturity Model Certification (CMMC) program, Foreign Risk Evaluation (FRE), and the disclosure of any organizational conflicts of interest.
U.S. Army

POSTED

1 day ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
Grant
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)The Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN) is a National Institutes of Health initiative focused on conducting implementation science research to combat adolescent HIV. By developing and testing scalable, low-resource care delivery models in low- and middle-income countries, the network aims to generate robust evidence on HIV incidence, prevention uptake, and viral suppression. These international studies leverage large adolescent populations and innovative, cost-effective service delivery methods to create practice-ready strategies that can be adapted for marginalized and high-burden populations within the United States. The program addresses critical gaps in the U.S. healthcare system where adolescents face similar barriers to care as those in resource-constrained global settings, including poverty, stigma, and fragmented services. Comprising Clinical Research Centers and a Data and Coordinating Center, PATC3H-IN supports the goals of the Ending the HIV Epidemic in the U.S. initiative by accelerating the translation of resilient and cost-conscious care models into domestic practice. This effort is authorized under the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve overall care outcomes and prevent new HIV acquisitions among at-risk youth.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

29 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

N/A
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Prepare for this forecast

Research this forecast and prepare for the solicitation

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS